Left ventricle assist systems: A possible alternative to heart transplantation for heart failure patients? Patient selection, techniques and benefit

European Journal of Heart Failure

Volumn 1, Issue 4, 1999, Pages 319-325

  Gronda, Edoardo ^a   Vitali, Ettore ^a  

^a Granda Hospital   (Italy)

Author keywords

Congestive heart failure; Heart transplantation; Left ventricle assist device

Indexed keywords

NEUROHORMONE;

ARTIFICIAL HEART; CONGESTIVE HEART FAILURE; HEART ASSIST DEVICE; HEART TRANSPLANTATION; HUMAN; IMPLANTATION; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW;

HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART, ARTIFICIAL; HEART-ASSIST DEVICES; HUMANS; PATIENT SELECTION;

EID: 0033494354     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(99)00033-1     Document Type: Review

References (38)

1. O'Connell J.B., Bristow M.R. Economic impact of heart failure in the United States: time for a new approach. J Heart Lung Transplant. 13:1994;S107-112.
2. Lenfant C. Report of the task force on research in heart failure. Circulation. 90:1994;1118-1123.
3. National Center of Health Statistics, Graves EJ. Detailed diagnoses and procedures, National Hospital Discharge Survey, 1989. Vital and health statistics 1991. Series 13, No. 107. US Department of Health and Human Services, DHHS Publication No. (PHS)91-1768. Washington, DC: US Government Printing Office, 1991.
4. Hok K.L., Pinsky J.L., Kannel W.B., Levy D. The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol. 22(suppl. A):1993;6A-13A.
5. Effects of Enalapril on mortality in congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 316:1987;1429-1435.
6. Stevenson L.W., Warner S.L., Steimer E.A. et al. The impending crisis awaiting cardiac transplantation. Circulation. 89:1994;450-457.
7. Lejemtel T.H., Sonnenblick E.H. Heart failure adaptative and maladaptative processes: introduction. Circulation. 87(suppl. VII):1993;1-4.
8. Colombo T., Borrello B., Lanfranconi L. et al. Trapianto cardiaco 1985-1995: 10 anni di esperienza al Centro 'Angelo De Gasperis': Miglioramento dei risultati mediante l' evoluzione dei criteri operativi. G Ital Cardiol. 27(1):1997;3-18.
9. Frigerio M., Gronda E.G., Mangiavacchi M. et al. Restrictive criteria for heart transplantation candidacy maximize survival of patients with advanced heart failure. J Heart Lung Transplant. 16:1997;160-168.
10. Hosenpud J.D., Bennet L.E., Keck B.M., Fiol B., Novick J.R. The registry of the International Society for Heart and Lung Transplantation: fourteenth official report 1997. J Heart Lung Transplant. 16:1997;691-712.
11. Pae W.E. Jr, Miller Ca., Mathews Y., Pierce W.S. Ventricular assist devices for postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg. 10:1992;541-552.
12. Karl TR. Extracorporeal circulatory support in infants and children. Sem Thorac Cardiovasc Surg 1994:154-160.
13. Chen J., Levin H., Catanese K., Sistino J., Landry D., Rose A.E., Oz M.L. Use of pulsatile right ventricular assist device and continuous arteriovenous hemodialysis in a 57-year-old man with a pulsatile left ventricular assist device. J Heart Lung Transplant. 14:1995;186-191.
14. Arabia F.A., Smith R.G., Rose D.S., Arzounman D.A., Sethi G.K., Copeland J.G. Success rates of long term circulatory assist devices used currently for bridge to heart transplantation. ASAIOJ. 42:1996;M542-M546.
15. Shinn G.A., Oyer P.E. Novacor ventricular assist system. Qual S.J. Cardiac mechanical assistance beyond balloon pumping. 1993;99 CV Mosby, St. Louis, MO.
16. Frazier O.H., Rose A.E., Macmanus Q. et al. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg. 53:1992;1080-1090.
17. De Rose J.J., Argenziano M., Sun B.C., Reemtsma K., Oz M.C., Rose E.A. Implantable left ventricular assist devices: an evolving long-term cardiac replacement therapy. Ann Surg. 226:1997;461-468.
18. Goldstein D.J., Seldomridge J.A., Chen J.M. et al. Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg. 59:1995;1063-1067.
19. Shenkar R., Coulson W.F., Abraham E. Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury. Am J Respir Cell Mol Biol. 10:1994;290-297.
20. Argenziano M., Choudhri A.F., Moazami N. et al. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg. 65:1998;340-345.
21. Rose E.A., Levin H.R., Oz M.C., Frazier O.H., McManus Q., Burton N.A., Lefrack E.A. Artificial circulatory support with textured interior surfaces: a counterintuitive approach to minimizing thromboembolism. Circulation. 90(II):1994;87-91.
22. Chen J., Levine H., Catanese K., Sistino J., Landry D., Rose E.A., Oz M.I. Use of pulsatile right ventricle assist device and continuous arteriovenous haemodyalisis in a 57 year old man with a pulsatile left ventricular assist device. J Heart Lung Transplant. 14:1995;186-191.
23. Miller L.W. Mechanical assist devices in intensive care. Am Heart J. 121:1991;1887-1992.
24. Stevenson L.W. Tailored therapy before transplantation to effective treatment of advanced heart failure: effective use of vasodilators and diuretics. J Heart Lung Transplant. 10:1991;468-476.
25. Cohn J.N., Rector T.S. Prognosis of congestive heart failure and predictors of mortality. Am J Cardiol. 62:1988;25A-30A.
26. Gradman A., Deedwania P., Cody R., Massie B., Packer M., Pitt B., Goldstein S. Predictors of total mortality and sudden death in mild to moderate heart failure: Captopril Digoxin Study Group. J Am Coll Cardiol. 14:1989;564-570.
27. Fonarow G.C., Chelimsky-Fallick C., Stevenson W.G., Luu M., Hamilton M.A., Moriguchi J.D., Tillish J.H., Creaser J.A., Albanese E. Effect of direct vasodilatation vs angiotensin converting enzyme inhibition on mortality in advanced heart failure: the Hy-C Trial. J Am Coll Cardiol. 19:1992;842-845.
28. Adams K.F., Zannad F. Clinical definition and epidemiology of advanced heart failure. Heart Failure J. 135:1998;S204-S215.
29. Stevenson L.W. When is heart failure a surgical disease? Rose E., Stevenson L.W. Management of end stage heart failure. 1998;129-146 Lippincott Raven Publishers, Philadelphia.
30. Oliva F, Latini R, Politi A, Staszewski L, Maggioni AP, Nicolls E, Mauri F for the DICE (Dobutamina nell'insufficienza cardiaca Estrema) Investigators. Intermittent 6-month low dose dobutamine infusion in severe heart failure: Dice Multicenter Trial. Am Heart J 1999;138:247-253.
31. Foray A., Williams D., Reemtsa K., Oz M.C., Mancini D. Assessment of submassimal exercise capacity in patients with left ventricular assist device close to their normal life style'. Circulation. 94(Suppl. II):1996;222-226.
32. Gronda E., Frigerio M., Mangiavacchi M., Oliva F. et al. Cumulative and preoperative survival in heart transplant candidates needing inotropic support: a multivariable analysis. J Heart Lung Transplant. 15:1996;S40-47.
33. Gronda E.G., Barbieri P., Frigerio M. et al. Prognostic indices in heart transplant candidates after the first hospitalization triggered by the need for intravenous pharmacologic circulatory support. J Heart Lung Transplant. 18:1999;654-663.
34. Keith M., Geranmyegan A., Sole M.J. et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cariol. 31:1998;1352-1356.
35. Vilceck J., Lee T.H. Tumor necrosis factor. J Biol Chem. 266:1991;7313-7316.
36. Mann D.L., Young J.B. Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest. 105:1994;897.
37. Strober W., Cohen L.S., Waldmann T.A., Baunwald E. Tricuspid regurgitation a newly recognized cause protein losing-enteropathy, lymphocytopenia and immunologic deficiency. Am J Med. 44:1968;842.
38. Oz M.C., Goldstein D.J., Pepino T. et al. Screening scale predicts successfully receiving long term implantable left ventricle assist device. Circulation. 92(suppl. II):1995;169-173.